Stratatech Corporation
26Patents
20Active
26Granted
45Portfolio score
Filing activity: Aug 1, 2003 → Oct 2, 2018 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7541188B2 | Skin substitutes and uses thereof | Chemistry; Metallurgy | 12 | Expired |
| US7674291B2 | Human skin equivalents expressing exogenous polypeptides | Chemistry; Metallurgy | 11 | Expired |
| US7462448B2 | Species specific DNA detection | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7888496B2 | Kit for species specific DNA detection | Emerging Cross-Sectional Technologies | 9 | Active |
| US7955790B2 | Skin substitutes with improved barrier function | Chemistry; Metallurgy | 9 | Active |
| US7807148B2 | Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a | Chemistry; Metallurgy | 9 | Expired |
| US8092531B2 | Human skin equivalents expressing exogenous polypeptides | Chemistry; Metallurgy | 4 | Active |
| US7915042B2 | Keratinocytes expressing exogenous angiogenic growth factors | Chemistry; Metallurgy | 4 | Active |
| US7988959B2 | Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a | Chemistry; Metallurgy | 4 | Active |
| US8808685B2 | Method of treatment using organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1α | Chemistry; Metallurgy | 2 | Active |
| US8790636B2 | Human skin equivalents expressing exogenous polypeptides | Chemistry; Metallurgy | 2 | Active |
| US8992997B2 | Dried and irradiated skin equivalents for ready use | Human Necessities | 2 | Active |
| US8685463B2 | Dried and irradiated skin equivalents for ready use | Human Necessities | 2 | Active |
| US8580314B2 | Dried and irradiated skin equivalents for ready use | Human Necessities | 2 | Active |
| US10743533B2 | Cold storage of organotypically cultured skin equivalents for clinical applications | Human Necessities | 0 | Active |
| US9163076B2 | Human skin equivalents expressing exogenous polypeptides | Chemistry; Metallurgy | 0 | Expired |
| US11297829B2 | Cryopreservation of viable human skin substitutes | Human Necessities | 0 | Active |
| US10091983B2 | Cryopreservation of viable human skin substitutes | Human Necessities | 0 | Active |
| US9295543B2 | Skin substitutes with improved purity | Chemistry; Metallurgy | 0 | Active |
| US9526748B2 | Human skin equivalents expressing exogenous polypeptides | Chemistry; Metallurgy | 0 | Active |
| US9216202B2 | Methods and compositions for selecting cells with increased potency | Chemistry; Metallurgy | 0 | Expired |
| US9867904B2 | Dried and irradiated skin equivalents for ready use | Human Necessities | 0 | Active |
| US11911444B2 | Use of human skin substitutes expressing exogenous IL-12 to treat a wound bed | Chemistry; Metallurgy | 0 | Active |
| US10918768B2 | Human skin equivalents expressing exogenous polypeptides | Chemistry; Metallurgy | 0 | Active |
| US9526811B2 | Dried and irradiated skin equivalents for ready use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.